Multiple myeloma therapies

Abstract

Multiple myeloma (MM), which is caused by the transformation and uncontrolled proliferation of blood cells that normally produce antibodies1, is the second most common haematological cancer worldwide. Traditional therapies include chemotherapy, steroids and stem-cell transplantation, which typically result in median survival times of 3–5 years1. However… (More)
DOI: 10.1038/nrd2269

3 Figures and Tables

Topics

  • Presentations referencing similar topics